NUS
Nu Skin Enterprises Inc - A
NYSE · Consumer products
$10.81
+0.34 (+3.25%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.70B | 1.97B | 229.65M | 239.11M | 240.56M |
| Net Income | -143,900,468 | -150,087,404 | 20.80M | 17.26M | 21.16M |
| EPS | — | — | — | — | — |
| Profit Margin | -8.5% | -8.0% | 9.1% | 7.2% | 8.8% |
| Rev Growth | -13.7% | -13.7% | +7.3% | +7.9% | +9.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 100.53M | 100.53M | 106.00M | 116.04M | 131.43M |
| Total Equity | 162.96M | 162.96M | 357.90M | 382.53M | 420.07M |
| D/E Ratio | 0.62 | 0.62 | 0.30 | 0.30 | 0.31 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -77,385,867 | -85,197,095 | 27.05M | 32.19M | 32.46M |
| Free Cash Flow | — | — | 9.82M | 8.63M | 9.23M |